Corrona LLC, a sponsor of registries in immune-mediated diseases, announces the expansion of its dermatology network and real-world evidence program to include an Atopic Dermatitis Registry.

The Corrona Psoriasis Registry, developed in collaboration with the National Psoriasis Foundation and launched in 2015, was Corrona’s first dermatology registry and currently has over 200 sites and 12,000 patients, a media release from Corrona LLC explains in a media release.

“We’re excited to have the unique opportunity this international registry presents to the atopic dermatitis research community.”

— Eric Simpson, Professor of Dermatology and Director of Clinical Research at Oregon Health & Science University in Portland, and Scientific Co-Director of the registry

Serve as the Real-World Gold Standard

The registry’s objective is to serve as the gold standard for real-world evidence generation in atopic dermatitis on drug effectiveness and safety. Corrona expects to enroll and follow more than 10,000 individuals with moderate to severe disease and will collect detailed information about the patient journey including treatment history and current therapies, comorbidities, clinical measures of effectiveness, disease phenotypes, adverse events, and quality of life from patients and their treating dermatology practitioners.

“The Corrona registry will serve as a robust data source for refining our understanding of moderate to severe atopic dermatitis and exploring comparative effectiveness and safety of emerging therapies.”

— Dr. Jonathan Silverberg, Associate Professor of Dermatology, George Washington University School of Medicine and Health Sciences in Washington, DC, and Scientific Co-Director of the registry

“We are delighted to build upon our dermatology site network by expanding into atopic dermatitis and continue our commitment to generate fit-for-purpose, high-quality evidence that will provide meaningful clinical insights.”

— Dr. Jeff Greenberg, Chief Medical Officer of Corrona

[Source(s): Corrona LLC, PR Newswire]

Related Content:
Transgender Patients Have Increased Risk for Acne, Androgenetic Alopecia, Atopic Dermatitis
Researcher IDs Gene Biomarker That Differentiates Between Atopic Dermatitis and Psoriasis
Addressing Skin Pain in Atopic Dermatitis